Molecular Signatures in Inflammatory Skin Disease
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Dupilumab
Related studies linked through entity extraction aliases.
Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to <6 Years With Moderate-to-Severe Atopic Dermatitis (Liberty AD PRESCHOOL)
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Study to Investigate the Efficacy and Safety of Dupilumab Administered With Topical Corticosteroids (TCS) in Participants ≥6 to <12 Years With Severe Atopic Dermatitis (AD)
- Status
- COMPLETED
- Phase
- PHASE3
Immunogenetic Profiling of Dupilumab for the Treatment of Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE4
Study of REGN3500 and Dupilumab in Patients With Asthma
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of Dupilumab in Participants ≥12 to <18 Years of Age, With Moderate-to-severe Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE3
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE1
Dupilumab Compassionate Use Study
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Evaluation of Dupilumab in Children With Uncontrolled Asthma
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Assess the Efficacy and Safety of Dupilumab in Participants With Severe Atopic Dermatitis (AD) That Are Not Controlled With Oral Cyclosporine A (CSA) or for Those Who Cannot Take Oral CSA Because it is Not Medically Advisable
- Status
- COMPLETED
- Phase
- PHASE3
Open Label, Drug-Drug Interaction (DDI) Study of Dupilumab (REGN668/SAR231893) in Patients With Moderate to Severe Atopic Dermatitis (AD)
- Status
- COMPLETED
- Phase
- PHASE1
Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to <18 Years of Age With Atopic Dermatitis (AD)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Evaluation of Dupilumab in Patients With Severe Steroid Dependent Asthma
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest)
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Determine the Safety and Tolerability of Dupilumab (REGN668/SAR231893) in Patients Aged ≥6 to <18 Years With Atopic Dermatitis (Eczema)
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Confirm the Efficacy and Safety of Different Dupilumab Dose Regimens in Adults With Atopic Dermatitis (AD)
- Status
- COMPLETED
- Phase
- PHASE3
Study of Dupilumab in Adult Participants With Active Eosinophilic Esophagitis (EoE)
- Status
- COMPLETED
- Phase
- PHASE2
Study of Dupilumab (REGN668/SAR231893) Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE3
Study of Dupilumab Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE3
Study to Assess the Efficacy and Long-term Safety of Dupilumab (REGN668/SAR231893) in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE3